Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(4S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone is a chiral compound characterized by its colorless solid form. It is a versatile chiral auxiliary used in asymmetric synthesis, which is a crucial aspect of modern organic chemistry. (4S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone is also an intermediate in the preparation of Albaconazole, a pharmaceutical compound.

101711-78-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 101711-78-8 Structure
  • Basic information

    1. Product Name: (4S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone
    2. Synonyms: N-PROPIONYL-(4S)-BENZYL-2-OXAZOLIDINONE;N-3-PROPIONYL-(4S)-BENZYL-2-OXAZOLIDINONE;(S)-(+)-4-BENZYL-3-PROPIONYL-2-OXAZOLIDINONE;(S)-4-BENZYL-3-PROPIONYL-2-OXAZOLIDINONE;(4S)-(+)-4-BENZYL-3-PROPIONYL-2-OXAZOLIDINONE;(S)-(+)-4-Benzyl-3-propiomyl-2-oxazolidinone;(S)-(+)-4-BENZYL-3-PROPIONYL-2-OXAZOLIDI N-ONE, 99% (99% EE/HPLC);(4s)-(+)-benzyl-3-propionyl-2-oxazolidinone
    3. CAS NO:101711-78-8
    4. Molecular Formula: C13H15NO3
    5. Molecular Weight: 233.26
    6. EINECS: N/A
    7. Product Categories: Oxazolidinone;API intermediates;Asymmetric Synthesis;Chiral Building Blocks;Glycidyl Compounds, etc. (Chiral);Synthetic Organic Chemistry;Peptide;Asymmetric Synthesis;Chiral Auxiliaries;Oxazolidinone Derivatives;Aromatics;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals
    8. Mol File: 101711-78-8.mol
  • Chemical Properties

    1. Melting Point: 42-44 °C
    2. Boiling Point: 375.51°C (rough estimate)
    3. Flash Point: 193.7 °C
    4. Appearance: /
    5. Density: 1.1475 (rough estimate)
    6. Vapor Pressure: 1.68E-06mmHg at 25°C
    7. Refractive Index: 103 ° (C=1, EtOH)
    8. Storage Temp.: Inert atmosphere,Room Temperature
    9. Solubility: Chloroform, Methanol
    10. PKA: -2.35±0.40(Predicted)
    11. CAS DataBase Reference: (4S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone(CAS DataBase Reference)
    12. NIST Chemistry Reference: (4S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone(101711-78-8)
    13. EPA Substance Registry System: (4S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone(101711-78-8)
  • Safety Data

    1. Hazard Codes: Xi,Xn
    2. Statements: 36/37/38-20/21/22-43
    3. Safety Statements: 37/39-26-36-36/37
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 101711-78-8(Hazardous Substances Data)

101711-78-8 Usage

Uses

1. Used in Pharmaceutical Industry:
(4S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone is used as a chiral auxiliary for asymmetric synthesis, which is essential for the development of enantiomerically pure drugs. The compound plays a significant role in creating chiral molecules with specific spatial arrangements, which are crucial for the desired biological activity and to avoid potential side effects caused by the less desired enantiomer.
2. Used in Chemical Synthesis:
(4S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone is used as an intermediate in the preparation of Albaconazole, a pharmaceutical compound with potential applications in treating various medical conditions. Its role in the synthesis process highlights its importance in the development of new drugs and therapeutic agents.
3. Used in Research and Development:
As a versatile chiral auxiliary, (4S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone is also utilized in research and development for the creation of novel chiral compounds with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science. Its ability to induce chirality in synthesized products makes it a valuable tool for scientists and researchers working on the development of new molecules with specific properties and functions.

Check Digit Verification of cas no

The CAS Registry Mumber 101711-78-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,7,1 and 1 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 101711-78:
(8*1)+(7*0)+(6*1)+(5*7)+(4*1)+(3*1)+(2*7)+(1*8)=78
78 % 10 = 8
So 101711-78-8 is a valid CAS Registry Number.
InChI:InChI=1/C13H15NO3/c1-2-12(15)14-11(9-17-13(14)16)8-10-6-4-3-5-7-10/h3-7,11H,2,8-9H2,1H3/t11-/m0/s1

101711-78-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B2166)  (S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone  >96.0%(GC)

  • 101711-78-8

  • 1g

  • 580.00CNY

  • Detail
  • TCI America

  • (B2166)  (S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone  >96.0%(GC)

  • 101711-78-8

  • 5g

  • 1,750.00CNY

  • Detail
  • Aldrich

  • (458775)  (S)-(+)-4-Benzyl-3-propionyl-2-oxazolidinone  99%

  • 101711-78-8

  • 458775-5G

  • 2,459.34CNY

  • Detail

101711-78-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-4-Benzyl-3-propionyloxazolidin-2-one

1.2 Other means of identification

Product number -
Other names (4S)-4-benzyl-3-propanoyl-1,3-oxazolidin-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:101711-78-8 SDS

101711-78-8Relevant articles and documents

Simple and efficient N-acylation reactions of chiral oxazolidinone auxiliaries

Ager, David J.,Allen, David R.,Schaad, David R.

, p. 1283 - 1285 (1996)

A simplified procedure for the N-acylation of oxazolidin-2-one chiral auxiliaries has been developed. The acylations occur at room temperature in the presence of triethylamine and catalytic quantities of 4-(N,N-dimethylamino)pyridine, thereby eliminating the necessity for a strong base such as butyllithium. Acylations with both symmetrical and mixed anhydrides, as well as acid chlorides, occur with a wide variety of oxazolidinone auxiliaries.

Substrate structure-activity relationships guide rational engineering of modular polyketide synthase ketoreductases

Bailey, Constance B.,Pasman, Marjolein E.,Keatinge-Clay, Adrian T.

, p. 792 - 795 (2016)

Modular polyketide synthase ketoreductases can set two chiral centers through a single reduction. To probe the basis of stereocontrol, a structure-activity relationship study was performed with three α-methyl, β-ketothioester substrates and four ketoreductases. Since interactions with the β-ketoacyl moiety were found to be most critical, residues implicated in contacting this moiety were mutated. Two mutations were sufficient to completely reverse the stereoselectivity of the model ketoreductase EryKR1, converting it from an enzyme that generates (2S,3R)-products into one that yields (2S,3S)-products.

A Synthesis Strategy for the Production of a Macrolactone of Gulmirecin A via a Ni(0)-Mediated Reductive Cyclization Reaction

Ichikawa, Satoshi,Katsuyama, Akira,Kitahata, Shun

, (2020)

A synthesis strategy for the production of a key synthetic intermediate of gulmirecin A was described. The key reaction in the preparation of the 12-membered macrolactone is the Ni(0)-mediated reductive cyclization reaction of ynal using an N-heterocyclic carbene ligand and silane reductant. In addition, the α-selective glycosylation reaction of the macrolactone was performed to demonstrate the synthesis of gulmirecin and disciformycin precursors.

Modular Synthesis of Diverse Natural Product-Like Macrocycles: Discovery of Hits with Antimycobacterial Activity

Dow, Mark,Marchetti, Francesco,Abrahams, Katherine A.,Vaz, Luis,Besra, Gurdyal S.,Warriner, Stuart,Nelson, Adam

, p. 7207 - 7211 (2017)

A modular synthetic approach was developed in which variation of the triplets of building blocks used enabled systematic variation of the macrocyclic scaffolds prepared. The approach was demonstrated in the synthesis of 17 diverse natural product-like macrocyclic scaffolds of varied (12–20-membered) ring size. The biological relevance of the chemical space explored was demonstrated through the discovery of a series of macrocycles with significant antimycobacterial activity.

DCC/DMAP-Mediated Coupling of Carboxylic Acids with Oxazolidinones and Thiazolidinethiones

Andrade, Carlos Kleber Z.,Rocha, Rafael O.,Vercillo, Otilie E.,Silva, Wender A.,Matos, Ricardo Alexandre F.

, p. 2351 - 2352 (2003)

Dicyclohexylcarbodiimide and catalytic dimethylaminopyridine were successfully used in the coupling of carboxylic acids with oxazolidinones and thiazolidinethiones. The acylated products were obtained in good yields.

Novel chiral stationary phases based on 3,5-dimethyl phenylcarbamoylated β-cyclodextrin combining cinchona alkaloid moiety

Zhu, Lunan,Zhu, Junchen,Sun, Xiaotong,Wu, Yaling,Wang, Huiying,Cheng, Lingping,Shen, Jiawei,Ke, Yanxiong

, p. 1080 - 1090 (2020)

Novel chiral selectors based on 3,5-dimethyl phenylcarbamoylated β-cyclodextrin connecting quinine (QN) or quinidine (QD) moiety were synthesized and immobilized on silica gel. Their chromatographic performances were investigated by comparing to the 3,5-dimethyl phenylcarbamoylated β-cyclodextrin (β-CD) chiral stationary phase (CSP) and 9-O-(tert-butylcarbamoyl)-QN-based CSP (QN-AX). Fmoc-protected amino acids, chiral drug cloprostenol (which has been successfully employed in veterinary medicine), and neutral chiral analytes were evaluated on CSPs, and the results showed that the novel CSPs characterized as both enantioseparation capabilities of CD-based CSP and QN/QD-based CSPs have broader application range than β-CD-based CSP or QN/QD-based CSPs. It was found that QN/QD moieties play a dominant role in the overall enantioseparation process of Fmoc-amino acids accompanied by the synergistic effect of β-CD moiety, which lead to the different enantioseparation of β-CD-QN-based CSP and β-CD-QD-based CSP. Furthermore, new CSPs retain extraordinary enantioseparation of cyclodextrin-based CSP for some neutral analytes on normal phase and even exhibit better enantioseparation than the corresponding β-CD-based CSP for certain samples.

The perils of rational design-unexpected irreversible elimination of fluoride from 3-fluoro-2-methylacyl-CoA esters catalysed by α-methylacyl-CoA racemase (AMACR; P504S)

Yevglevskis, Maksims,Lee, Guat L.,Threadgill, Michael D.,Woodman, Timothy J.,Lloyd, Matthew D.

, p. 14164 - 14166 (2014)

α-Methylacyl-CoA racemase (AMACR; P504S) catalyses 'racemization' of 2-methylacyl-CoAs, the activation of R-ibuprofen and is a promising cancer drug target. Human recombinant AMACR 1A catalyses elimination of 3-fluoro-2-methyldecanoyl-CoAs to give E-2-methyldec-2-enoyl-CoA and fluoride anion, a previously unknown reaction. 'Racemization' of 2-methyldec-3-enoyl-CoAs was also catalysed, without double bond migration. This journal is

Stapled Peptides with γ-Methylated Hydrocarbon Chains for the Estrogen Receptor/Coactivator Interaction

Speltz, Thomas E.,Fanning, Sean W.,Mayne, Christopher G.,Fowler, Colin,Tajkhorshid, Emad,Greene, Geoffrey L.,Moore, Terry W.

, p. 4252 - 4255 (2016)

"Stapled" peptides are typically designed to replace two non-interacting residues with a constraining, olefinic staple. To mimic interacting leucine and isoleucine residues, we have created new amino acids that incorporate a methyl group in the γ-position of the stapling amino acid S5. We have incorporated them into a sequence derived from steroid receptor coactivator2, which interacts with estrogen receptorα. The best peptide (IC50=89nm) replaces isoleucine689 with an S-γ-methyl stapled amino acid, and has significantly higher affinity than unsubstituted peptides (390 and 760nm). Through X-ray crystallography and molecular dynamics studies, we show that the conformation taken up by the S-γ-methyl peptide minimizes the syn-pentane interactions between the α- and γ-methyl groups.

β N-O turns and helices induced by β2-aminoxy peptides: Synthesis and conformational studies

Jiao, Zhi-Gang,Chang, Xiao-Wei,Ding, Wei,Liu, Guo-Jun,Song, Ke-Sheng,Zhu, Nian-Yong,Zhang, Dan-Wei,Yang, Dan

, p. 1791 - 1799 (2011)

Herein, we report an efficient route for the asymmetric synthesis of β2-aminoxy acids as well as experimental and theoretical studies of conformations of peptides composed of β2-aminoxy acids. The nine-membered-ring intramolecular hydrogen bonds, namely, β N-O turns, are generated between adjacent residues in those peptides, in accordance with our computational results. The presence of two consecutive homochiral β N-O turns leads to the formation of β N-O helical structures in solution, although both helical (composed of two β N-O turns of the same handedness) and reverse-turn (composed of two β N-O turns with opposite handedness) structures are of similar stability, as suggested by theoretical studies. Nevertheless, two slightly different conformations, with the same handedness, of β2-aminoxy monomers have been observed in the solid state and in solution according to our X-ray and 2D NOESY studies.

Thermal proteome profiling efficiently identifies ribosome destabilizing oxazolidinones

N?cker, Christina,Kaiser, Nadine,Foley, Daniel,Sievers, Sonja,Janning, Petra,Waldmann, Herbert,Laraia, Luca

supporting information, (2021/04/22)

Identifying the targets of bioactive small molecules is a challenging endeavor for which no general solution currently exists. Classical affinity purification experiments suffer from the need to functionalise a bioactive compound and link it to a solid support, which may interfere with target binding. A modern mass spectrometry-based proteomics technique that has partially circumvented this problem is thermal proteome profiling (TPP), which determines the effect of an unmodified small molecule on the thermal stability of the whole proteome simultaneously. Here, we use TPP to identify the mode-of-action of a newly-discovered autophagy inhibitor based on oxazolidinones often employed as chiral auxiliaries. Surprisingly, a significant portion of all ribosomal proteins were found to be destabilized by the inhibitor, highlighting the utility of this technology for determining a challenging mode-of-action.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 101711-78-8